Evidence map›Paper›PMID 32267846›Full record

ArticlePLoS neglected tropical diseases2020

Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques.

Michael K McCracken, Gregory D Gromowski, Lindsey S Garver, Brad A Goupil, Kathryne D Walker, Heather Friberg, Jeffrey R Currier, Wiriya Rutvisuttinunt, Kevin L Hinton, Rebecca C Christofferson and 9 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Dengue and severe dengue.Clinical microbiology reviews · 2025
    Review
  7. Review
  8. iScience · 2024
    Article
  9. Article
  10. Review
  11. bioRxiv : the preprint server for biology · 2024
    Article
  12. iScience · 2024
    Article
  13. Oxford open immunology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Michael K McCrackenViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.ORCID 0000-0002-4035-5485
Gregory D GromowskiViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Lindsey S GarverEntomology Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Brad A GoupilDepartment of Pathobiological Sciences, Louisiana State University, Baton Rouge, Louisiana, United States of America.
Kathryne D WalkerEntomology Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Heather FribergViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.ORCID 0000-0001-5173-2701
Jeffrey R CurrierViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Wiriya RutvisuttinuntViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Kevin L HintonVeterinary Services Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Rebecca C ChristoffersonDepartment of Pathobiological Sciences, Louisiana State University, Baton Rouge, Louisiana, United States of America.ORCID 0000-0003-2806-1131
Christopher N MoresDepartment of Pathobiological Sciences, Louisiana State University, Baton Rouge, Louisiana, United States of America.ORCID 0000-0001-6678-9049
Yannick VanloubbeeckGSK Vaccines, Rixensart, Belgium.
Clarisse LorinGSK Vaccines, Rixensart, Belgium.
Marie-Pierre MaliceGSK Vaccines, Rixensart, Belgium.
Stephen J ThomasViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Richard G JarmanViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
David W VaughnGSK Vaccines, Rockville, Maryland, United States of America.
J Robert PutnakViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.ORCID 0000-0003-1815-545X
Lucile WarterGSK Vaccines, Rixensart, Belgium.ORCID 0000-0001-7419-9284
Walter Reed Army Institute of Research · USGlaxoSmithKline (Belgium) · BELouisiana State University · USGlaxoSmithKline (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue virus (DENV) is transmitted by infectious mosquitoes during blood-feeding via saliva containing biologically-active proteins. Here, we examined the effect of varying DENV infection modality in rhesus macaques in order to improve the DENV nonhuman primate (NHP) challenge model. NHPs were exposed to DENV-1 via subcutaneous or intradermal inoculation of virus only, intradermal inoculation of virus and salivary gland extract, or infectious mosquito feeding. The infectious mosquito feeding group exhibited delayed onset of viremia, greater viral loads, and altered clinical and immune responses compared to other groups. After 15 months, NHPs in the subcutaneous and infectious mosquito feeding groups were re-exposed to either DENV-1 or DENV-2. Viral replication and neutralizing antibody following homologous challenge were suggestive of sterilizing immunity, whereas heterologous challenge resulted in productive, yet reduced, DENV-2 replication and boosted neutralizing antibody. These results show that a more transmission-relevant exposure modality resulted in viral replication closer to that observed in humans.

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralDengueDengue VirusDisease Models, AnimalFemaleKineticsMacaca mulattaMosquito VectorsRNA, ViralSalivary GlandsVaccinationViral LoadViremiaVirus ReplicationAntibodies, NeutralizingAntibodies, ViralRNA, Viral

Identifiers

PMID32267846
PMCPMC7141610
OpenAlexW3014659867

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.